Trial Profile
Imiquimod in HIV-infected patients with high-grade anal canal intraepithelial neoplasia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2010
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Anal cancer; Anal intraepithelial neoplasia
- Focus Therapeutic Use
- 09 Nov 2010 New trial record